CD19 antibody-drug conjugate therapy in DLBCL does not preclude subsequent responses to CD19-directed CAR T-cell therapy
Bicky Thapa, Paolo F. Caimi, Kirit M. Ardeshna, Melhem Solh, Carmelo Carlo‐Stella, Brad S. Kahl, Mehdi Hamadani
Topics & Concepts
CD19MedicineAntibodyDrugAntibody therapyCAR T-cell therapyCell therapyConjugateAntibody-drug conjugateImmunologyPharmacologyChimeric antigen receptorT cellCellMonoclonal antibodyBiologyImmune systemMathematical analysisMathematicsGeneticsCAR-T cell therapy researchBiosimilars and Bioanalytical MethodsViral Infectious Diseases and Gene Expression in Insects